{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05892614",
            "orgStudyIdInfo": {
                "id": "ATYR1923-C-005"
            },
            "organization": {
                "fullName": "aTyr Pharma, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)",
            "officialTitle": "Randomized, Double-blind, Placebo-controlled Proof-of-Concept (PoC) Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)",
            "therapeuticArea": [
                "Respiratory"
            ],
            "study": "study-to-evaluate-the-efficacy-safety-and-tolerability-of-efzofitimod-in-patients-with-systemic-sclerosis-ssc-related-interstitial-lung-disease-ild-ssc-ild"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-04",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-10-26",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-05-12",
            "studyFirstSubmitQcDate": "2023-06-05",
            "studyFirstPostDateStruct": {
                "date": "2023-06-07",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-04-19",
            "lastUpdatePostDateStruct": {
                "date": "2024-04-22",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "aTyr Pharma, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is a double-blind, randomized, placebo-controlled, PoC study to evaluate the efficacy, safety, and tolerability of efzofitimod in patients with SSc-ILD. The primary objective of the study is to evaluate the PoC for efficacy in a population with SSc-ILD. While improvement of ILD is the outcome of interest, the study will also evaluate changes in the skin. After initial screening (up to 4 weeks), approximately 25 eligible participants will be randomized 2:2:1 to 1 of 2 active (experimental) dose arms or placebo, administered every 4 weeks up to and including Week 20."
        },
        "conditionsModule": {
            "conditions": [
                "Interstitial Lung Disease"
            ],
            "keywords": [
                "ILD",
                "SSc-ILD",
                "Interstitial Lung Disease",
                "lung inflammation",
                "fibrosis",
                "pulmonary function",
                "efzofitimod",
                "systemic sclerosis"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "TRIPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 25,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "efzofitimod 450 mg",
                    "type": "EXPERIMENTAL",
                    "description": "Administered IV infusion",
                    "interventionNames": [
                        "Drug: efzofitimod 450 mg"
                    ]
                },
                {
                    "label": "efzofitimod 270 mg",
                    "type": "EXPERIMENTAL",
                    "description": "Administered IV infusion",
                    "interventionNames": [
                        "Drug: efzofitimod 270 mg"
                    ]
                },
                {
                    "label": "Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Administered IV infusion",
                    "interventionNames": [
                        "Drug: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "efzofitimod 450 mg",
                    "description": "IV infusion over approximately 60 minutes every 4 weeks",
                    "armGroupLabels": [
                        "efzofitimod 450 mg"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "efzofitimod 270 mg",
                    "description": "IV infusion over approximately 60 minutes every 4 weeks",
                    "armGroupLabels": [
                        "efzofitimod 270 mg"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo",
                    "description": "IV infusion over approximately 60 minutes every 4 weeks",
                    "armGroupLabels": [
                        "Placebo"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Absolute change from baseline in forced vital capacity (FVC) in mL",
                    "timeFrame": "24 weeks"
                },
                {
                    "measure": "Annual rate of decline in FVC in mL",
                    "timeFrame": "24 weeks"
                },
                {
                    "measure": "Annual rate of decline in FVC in percent predicted",
                    "timeFrame": "24 weeks"
                },
                {
                    "measure": "Proportion of patients with > 5% and \u2265 10% decline in absolute FVC",
                    "timeFrame": "Baseline to week 24"
                },
                {
                    "measure": "Proportion of patients with > 5% and \u2265 10% decline in percent predicted FVC",
                    "timeFrame": "Baseline to Week 24"
                },
                {
                    "measure": "Change in HRCT fibrosis score",
                    "timeFrame": "Baseline to Week 24"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Diagnosis of SSc based on ACR/ EULAR criteria (2013)\n2. Overall duration of SSc \\< 48 months from the first non-Raynaud symptom manifestation\n3. HRCT obtained at the Screening Visit or within the 3 months prior to Screening consistent with SSc-ILD (adjudicated by a central reader) AND with pulmonary involvement \\> 10%\n4. Clinical presentation at Screening consistent with lcSSc (up to 40% of patients) or dcSSc\n5. Presence of at least:\n\n   Any 1 laboratory marker for active disease\n\n   OR\n\n   Clinically significant decline in FVC % predicted (%pred) based on \u2265 105% relative decline over the preceding one year (two readings from the same pulmonary function laboratory)\n6. MMF of \u2265 2 gm/day (or equivalent doses of other mycophenolate based compounds) for 6 months\n\nExclusion Criteria:\n\n1. Pulmonary disease with FVC %pred \u2264 45% OR DLco %pred \u2264 30%; FEV1/FVC ratio \\< 0.7\n2. Participants with pulmonary artery hypertension on parenteral therapy or with clinical evidence of right heart failure\n3. HRCT obtained in the 3 months prior to Screening consistent with other confounding pathology.\n4. Treatment with corticosteroids (\\> 10 mg/day of prednisone or equivalent) within 2 weeks prior to baseline\n5. SSc-ILD treatments other than MMF OR MMF \\< 2 gm/day\n6. Any previous treatment with any of the following: rituximab, intravenous immune globulin (IVIG), tocilizumab, cyclophosphamide, pirfenidone, tyrosine-kinase inhibitors (e.g., imatinib, nilotinib, dasatinib)\n7. Rheumatic autoimmune disease other than SSc, Is an active, heavy smoker of tobacco/nicotine-containing products\n8. History of (anti-Jo-1) anti-synthetase syndrome or Jo-1 positive at Screening",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "aTyr Pharma Clinical Research",
                    "role": "CONTACT",
                    "phone": "877-215-5731",
                    "email": "clinicaltrials@atyrpharma.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Lisa Carey",
                    "affiliation": "aTyr Pharma, Inc.",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "aTyr Investigative Site",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90024",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "877-689-4494",
                            "email": "SScILD@cssienroll.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "aTyr Investigative Site",
                    "status": "NOT_YET_RECRUITING",
                    "city": "San Diego",
                    "state": "California",
                    "zip": "92093",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "877-689-4494",
                            "email": "SScILD@cssienroll.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.71533,
                        "lon": -117.15726
                    }
                },
                {
                    "facility": "aTyr Investigative Site",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Miami",
                    "state": "Florida",
                    "zip": "33146",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "877-689-4494",
                            "email": "SScILD@cssienroll.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 25.77427,
                        "lon": -80.19366
                    }
                },
                {
                    "facility": "aTyr Investigative Site",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Chicago",
                    "state": "Illinois",
                    "zip": "60153",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "877-689-4494",
                            "email": "SScILD@cssienroll.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.85003,
                        "lon": -87.65005
                    }
                },
                {
                    "facility": "aTyr Investigative Site",
                    "status": "RECRUITING",
                    "city": "Chicago",
                    "state": "Illinois",
                    "zip": "60611",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "877-689-4494",
                            "email": "SScILD@cssienroll.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.85003,
                        "lon": -87.65005
                    }
                },
                {
                    "facility": "aTyr Investigative Site",
                    "status": "RECRUITING",
                    "city": "Chicago",
                    "state": "Illinois",
                    "zip": "60612",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "877-689-4494",
                            "email": "SScILD@cssienroll.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.85003,
                        "lon": -87.65005
                    }
                },
                {
                    "facility": "aTyr Investigative Site",
                    "status": "RECRUITING",
                    "city": "New Orleans",
                    "state": "Louisiana",
                    "zip": "70115",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "877-689-4494",
                            "email": "SScILD@cssienroll.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.95465,
                        "lon": -90.07507
                    }
                },
                {
                    "facility": "aTyr Investigative Site",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10027",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "877-689-4494",
                            "email": "SScILD@cssienroll.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "aTyr Investigative Site",
                    "status": "RECRUITING",
                    "city": "Cleveland",
                    "state": "Ohio",
                    "zip": "44195",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "877-689-4494",
                            "email": "SScILD@cssienroll.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.4995,
                        "lon": -81.69541
                    }
                },
                {
                    "facility": "aTyr Investigative Site",
                    "status": "RECRUITING",
                    "city": "Oklahoma City",
                    "state": "Oklahoma",
                    "zip": "73104",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "877-689-4494",
                            "email": "SScILD@cssienroll.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 35.46756,
                        "lon": -97.51643
                    }
                },
                {
                    "facility": "aTyr Investigative Site",
                    "status": "RECRUITING",
                    "city": "Charleston",
                    "state": "South Carolina",
                    "zip": "29425",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "877-689-4494",
                            "email": "SScILD@cssienroll.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.77657,
                        "lon": -79.93092
                    }
                },
                {
                    "facility": "aTyr Investigative Site",
                    "status": "RECRUITING",
                    "city": "Dallas",
                    "state": "Texas",
                    "zip": "75204",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "877-689-4494",
                            "email": "SScILD@cssienroll.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.78306,
                        "lon": -96.80667
                    }
                },
                {
                    "facility": "aTyr Investigative Site",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77204",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "877-689-4494",
                            "email": "SScILD@cssienroll.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "aTyr Investigative Site",
                    "status": "RECRUITING",
                    "city": "Salt Lake City",
                    "state": "Utah",
                    "zip": "84112",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "877-689-4494",
                            "email": "SScILD@cssienroll.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.76078,
                        "lon": -111.89105
                    }
                },
                {
                    "facility": "aTyr Investigative Site",
                    "status": "RECRUITING",
                    "city": "Richmond",
                    "state": "Virginia",
                    "zip": "23284",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "877-689-4494",
                            "email": "SScILD@cssienroll.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.55376,
                        "lon": -77.46026
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008171",
                    "term": "Lung Diseases"
                },
                {
                    "id": "D000017563",
                    "term": "Lung Diseases, Interstitial"
                },
                {
                    "id": "D000012595",
                    "term": "Scleroderma, Systemic"
                },
                {
                    "id": "D000045743",
                    "term": "Scleroderma, Diffuse"
                },
                {
                    "id": "D000012598",
                    "term": "Sclerosis"
                }
            ],
            "ancestors": [
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000012140",
                    "term": "Respiratory Tract Diseases"
                },
                {
                    "id": "D000003240",
                    "term": "Connective Tissue Diseases"
                },
                {
                    "id": "D000012871",
                    "term": "Skin Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M11168",
                    "name": "Lung Diseases",
                    "asFound": "Lung Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M19813",
                    "name": "Lung Diseases, Interstitial",
                    "asFound": "Interstitial Lung Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8485",
                    "name": "Fibrosis",
                    "relevance": "LOW"
                },
                {
                    "id": "M10293",
                    "name": "Inflammation",
                    "relevance": "LOW"
                },
                {
                    "id": "M15415",
                    "name": "Sclerosis",
                    "asFound": "Sclerosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M13904",
                    "name": "Pneumonia",
                    "relevance": "LOW"
                },
                {
                    "id": "M15412",
                    "name": "Scleroderma, Systemic",
                    "asFound": "Systemic Sclerosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M25560",
                    "name": "Scleroderma, Diffuse",
                    "asFound": "Systemic Sclerosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M14977",
                    "name": "Respiratory Tract Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M6464",
                    "name": "Connective Tissue Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M15674",
                    "name": "Skin Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T5565",
                    "name": "Systemic Scleroderma",
                    "asFound": "Systemic Sclerosis",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "BC01",
                    "name": "Infections"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}